These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 33930416)

  • 21. Vancomycin Resistance in
    McGuinness WA; Malachowa N; DeLeo FR
    Yale J Biol Med; 2017 Jun; 90(2):269-281. PubMed ID: 28656013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus.
    García AB; Candel FJ; López L; Chiarella F; Viñuela-Prieto JM
    J Med Microbiol; 2016 Oct; 65(10):1119-1122. PubMed ID: 27553740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phylogeny of hospital acquired MRSA, and its comparative phenotypic clinico-epidemiology with vancomycin resistant S. aureus (VRSA).
    Rehman TU; Aslam R; Aqib AI; Mohsin M; Manzoor A; Shoaib M; Naseer MA; Hasan A; Sattar H; Fakhar-E-Alam Kulyar M; Muzammil I; Yao W
    Microb Pathog; 2020 Dec; 149():104537. PubMed ID: 32980474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Yoneda A; Thänert R; Burnham CD; Dantas G
    Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
    Ozmen Capin BB; Tekeli A; Karahan ZC
    Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
    [No Abstract]   [Full Text] [Related]  

  • 27. Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence.
    Stefani S; Campanile F; Santagati M; Mezzatesta ML; Cafiso V; Pacini G
    Int J Antimicrob Agents; 2015 Sep; 46(3):278-89. PubMed ID: 26143590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
    Purrello SM; Garau J; Giamarellos E; Mazzei T; Pea F; Soriano A; Stefani S
    J Glob Antimicrob Resist; 2016 Dec; 7():178-186. PubMed ID: 27889013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genotyping and drug resistance of methicillin-resistant Staphylococcus aureus].
    Yao M; Guan L; Jia W; Wang L; Li G; Wu X; Sun T
    Zhonghua Shao Shang Za Zhi; 2014 Oct; 30(5):428-32. PubMed ID: 25572893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
    Bal AM; Gould IM
    Expert Opin Pharmacother; 2005 Oct; 6(13):2257-69. PubMed ID: 16218886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
    Kebriaei R; Lehman SM; Shah RM; Stamper KC; Kunz Coyne AJ; Holger D; El Ghali A; Rybak MJ
    Microbiol Spectr; 2023 Jun; 11(3):e0491822. PubMed ID: 37199616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular Characterization of Methicillin and Vancomycin Resistant
    Jahanshahi A; Zeighami H; Haghi F
    Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
    [No Abstract]   [Full Text] [Related]  

  • 37. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents.
    Chang J; Tasellari A; Wagner JL; Scheetz MH
    Expert Rev Anti Infect Ther; 2023; 21(12):1309-1325. PubMed ID: 37876291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Haynes AS; Maples H; Parker S
    J Pediatric Infect Dis Soc; 2023 May; 12(5):308-318. PubMed ID: 37144953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of the development of antibiotic resistance in Staphylococcus aureus.
    Schito GC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():3-8. PubMed ID: 16445718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
    Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.